aTyr Pharma Inc (LIFE)
2.00
0.00 (0.00%)
USD |
NASDAQ |
Mar 28, 12:11
aTyr Pharma Market Cap: 135.50M for March 28, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
March 27, 2024 | 135.50M |
March 26, 2024 | 129.74M |
March 25, 2024 | 130.08M |
March 22, 2024 | 132.11M |
March 21, 2024 | 136.86M |
March 20, 2024 | 136.86M |
March 19, 2024 | 135.50M |
March 18, 2024 | 132.45M |
March 15, 2024 | 134.82M |
March 14, 2024 | 109.76M |
March 13, 2024 | 110.43M |
March 12, 2024 | 102.52M |
March 11, 2024 | 101.26M |
March 08, 2024 | 100.63M |
March 07, 2024 | 105.06M |
March 06, 2024 | 107.59M |
March 05, 2024 | 105.69M |
March 04, 2024 | 113.28M |
March 01, 2024 | 120.88M |
February 29, 2024 | 121.51M |
February 28, 2024 | 120.24M |
February 27, 2024 | 126.57M |
February 26, 2024 | 122.78M |
February 23, 2024 | 120.88M |
February 22, 2024 | 119.61M |
Date | Value |
---|---|
February 21, 2024 | 124.67M |
February 20, 2024 | 118.98M |
February 16, 2024 | 127.84M |
February 15, 2024 | 121.83M |
February 14, 2024 | 121.51M |
February 13, 2024 | 120.88M |
February 12, 2024 | 124.67M |
February 09, 2024 | 124.67M |
February 08, 2024 | 124.67M |
February 07, 2024 | 105.06M |
February 06, 2024 | 104.42M |
February 05, 2024 | 107.59M |
February 02, 2024 | 111.38M |
February 01, 2024 | 101.26M |
January 31, 2024 | 100.94M |
January 30, 2024 | 101.89M |
January 29, 2024 | 102.52M |
January 26, 2024 | 99.99M |
January 25, 2024 | 98.09M |
January 24, 2024 | 97.46M |
January 23, 2024 | 97.46M |
January 22, 2024 | 98.09M |
January 19, 2024 | 94.93M |
January 18, 2024 | 89.87M |
January 17, 2024 | 92.08M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
10.89M
Minimum
Aug 14 2019
345.71M
Maximum
Sep 23 2021
79.09M
Average
72.23M
Median
Oct 21 2022
Market Cap Benchmarks
Vaxart Inc | 234.71M |
Allogene Therapeutics Inc | 769.37M |
AIM ImmunoTech Inc | 23.44M |
Protalix BioTherapeutics Inc | 93.14M |
Armata Pharmaceuticals Inc | 147.48M |
Market Cap Related Metrics
Price to Book Value | 1.495 |
Price | 2.00 |
Earnings Yield | -48.00% |